晚期肝细胞癌的免疫治疗现状综述A Status Quo Review of Immunotherapy for Advanced Hepatocellular Carcinoma
王靖超, 安斌斌, 王志鑫, 张灵强, 王海久, 樊海宁, 周 瀛
临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112849, December 16 2021
晚期原发性肝细胞癌免疫治疗现状及研究进展Current Status and Research Progress of Immunotherapy for Advanced Primary Hepatocellular Carcinoma
张海容, 马金华
临床医学进展Vol.13 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1361342, June 19 2023
预测肝细胞癌免疫治疗的预后Biomarkers of Immunotherapy for Hepatocellular Carcinoma
王奇峰, 王海久
临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122629, December 6 2023
PD-1抑制剂对非小细胞肺癌患者Mito+ T淋巴细胞免疫代谢影响模式Effect Model of PD-1 Inhibitors on Immune Metabolism of Mito+ T Lymphocytes in Patients with Non-Small Cell Lung Cancer
王 铮, 陈存海, 马学真
临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131145, January 31 2023
外周血淋巴细胞水平对血清CEA正常的结直肠癌患者的预后监测价值——淋巴细胞影响结直肠癌预后Prognosis Value of Peripheral Lymphocytes Count in Colorectal Cancer Patients with Normal Serum CEA—Lymphocytes Predict Prognosis of Colorectal Cancer
蔡雅诗, 周敏仪, 王 佳, 鲁伟群, 沈西凌, 黄志良 国家自然科学基金支持
临床医学进展Vol.11 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1111793, November 24 2021
CTSV是一种可能的肿瘤标志物并与肾上腺皮质癌的免疫浸润密切相关CTSV Is a Possible Tumor Marker and Is Closely Related to Immune Invasion of Ad-renal Cortical Carcinoma
孙振鹏, 王 荃, 穆垚名, 高健刚
临床医学进展Vol.13 No.4, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.134865, April 23 2023